InMed Provides Update on Progress of Its Development Program for Epidermolysis Bullosa
04 nov. 2015 05h00 HE
|
InMed Pharmaceuticals Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Nov. 4, 2015) - InMed Pharmaceuticals Inc. ("InMed") (CSE:IN)(OTCQB:IMLFF), a biopharmaceutical company specializing in the research...
InMed Appoints Paul Brennan as President & Chief Executive Officer
03 sept. 2015 06h00 HE
|
InMed Pharmaceuticals Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Sept. 3, 2015) - InMed Pharmaceuticals Inc. ("InMed" or "the Company") (CSE:IN)(OTCQB:IMLFF), a biopharmaceutical company specializing in the...
InMed Commences Development of Proprietary Drug Delivery System
02 sept. 2015 05h00 HE
|
InMed Pharmaceuticals Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Sept. 2, 2015) - InMed Pharmaceuticals Inc. ("InMed") (CSE:IN)(OTCQB:IMLFF) is pleased to announce it has initiated testing of a novel...
InMed Appoints Paul Brennan to the Board of Directors
25 août 2015 05h00 HE
|
InMed Pharmaceuticals Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Aug. 25, 2015) - InMed Pharmaceuticals Inc. ("InMed" or "the Company") (CSE:IN)(OTCQB:IMLFF), a biopharmaceutical company specializing in the...
InMed Pharmaceuticals Announces Progress in Orofacial Pain Program
20 août 2015 08h00 HE
|
InMed Pharmaceuticals Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Aug. 20, 2015) - InMed Pharmaceuticals Inc. ("InMed") (CSE:IN)(OTCQB:IMLFF), a biopharmaceutical company specializing in the research and...
InMed Announces Positive In-Vitro Study Results of INM-750 Targeting Epidermolysis Bullosa Simplex (EBS)
06 août 2015 05h00 HE
|
InMed Pharmaceuticals Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Aug. 6, 2015) - InMed Pharmaceuticals Inc. ("InMed") (CSE:IN)(OTCQB:IMLFF), a biopharmaceutical company specializing in the research and...
InMed Pharmaceuticals Inc. (IMLFF) to Present at the Small-Cap Stars Spring Conference 2015 at Convene in Times Square New York on June 10
04 juin 2015 08h00 HE
|
InMed Pharmaceuticals Inc.
NEW YORK, June 4, 2015 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (OTCMKTS:IMLFF), a clinical stage biopharmaceutical company, will be presenting at the Small-Cap Stars Spring Conference 2015 at...
InMed Adds Chronic Obstructive Pulmonary Disease (COPD) Program to Therapeutic Pipeline
03 juin 2015 06h00 HE
|
InMed Pharmaceuticals Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 3, 2015) - InMed Pharmaceuticals Inc. ("InMed") (CSE:IN)(OTCQB:IMLFF), a clinical stage biopharmaceutical company that specializes in...
InMed Pharmaceuticals Files Provisional Patent for Compositions Treating Eye Diseases
12 mai 2015 12h44 HE
|
InMed Pharmaceuticals Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 12, 2015) - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (CSE:IN)(OTCQB:IMLFF), announced today that it has filed a provisional...
InMed Awarded Grant for Proprietary Nanoparticle-Based Delivery System for Glaucoma Therapy
15 avr. 2015 06h00 HE
|
InMed Pharmaceuticals Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 15, 2015) - InMed Pharmaceuticals Inc. ("InMed") (CSE:IN)(OTCQB:IMLFF), a clinical stage biopharmaceutical company that...